Jeanne Madden, PhD
Associate Professor
Department of Pharmacy and Health Systems Sciences, School of Pharmacy and Pharmaceutical Sciences
Office: R218TF
Email: [email protected]
Phone: 617-373-8344
Dr. Madden’s research primarily concerns access to health care, the burden of costs on patients, and the consequences of health system changes. She has directed several federally-funded studies examining the impact of changes in pharmacy benefits on access to treatments for chronic illness. Ongoing work looks at food insecurity and affordability of medical care in Medicare, and the intensity and costs of care for individuals with life-limiting illness. Dr. Madden led a qualitative study gathering perspectives of individuals with bipolar disorder navigating different insurance benefits, and stakeholder engagement for the PCORI-sponsored parent grant evaluating the impact of high-deductible insurance plans on adolescents and adults with bipolar disorder. In recent research as part of the Mental Health Research Network, she led inquiries into the completeness of information in medical record data and the use of psychotropics among children with autism spectrum disorders. She is co-investigator on studies of the impact of FDA warnings about antidepressants and suicidality among youth. Past studies examined medication underuse and uncontrolled asthma in a commercially-insured population, access to and affordability of medicines in low- and middle-income countries, and maternal and infant outcomes following changes in hospitalization policies at childbirth. Dr. Madden has particular expertise in large datasets, measurement development and validation, and evaluation methods. She holds a secondary faculty appointment at her prior institution, the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute.
Education:
Post-Doctoral Fellowship – Harvard Medical School and Harvard Pilgrim Health Care Institute
Ph.D. – Health Policy, Harvard University
Sc.M. – Public Health, Harvard School of Public Health
A.B. – History, Brown University
Selected Publications:
Bamgbade BA, McManus DD, Briesacher BA, Lessard D, Mehawej J, Gurwitz JH, Tisminetzky M, Mujumdar S, Wang W, Malihot T, Abu HO, Waring M, Sogade F, Madden J, Pierre-Louis IC, Helm R, Goldberg R, Kramer AF, Saczynski JS. Medication cost-reducing behaviors in older adults with atrial fibrillation: The SAGE-AF study. J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):125-134. doi: 10.1016/j.japh.2022.08.030. Epub 2022 Sep 8. PubMed PMID: 36171156.
Lu CY, Zhang F, Wallace J, LeCates RF, Busch AB, Madden J, Callahan M, Foxworth P, Soumerai SB, Ross-Degnan D, Wharam JF. High-Deductible Health Plans Paired With Health Savings Accounts Increased Medication Cost Burden Among Individuals With Bipolar Disorder. J Clin Psychiatry. 2022 Mar 9;83(2). doi: 10.4088/JCP.20m13865. PubMed PMID: 35275453.
Madden JM, Bayapureddy S, Briesacher BA, Zhang F, Ross-Degnan D, Soumerai SB, Gurwitz JH, Galbraith AA. Affordability of Medical Care Among Medicare Enrollees. JAMA Health Forum. 2021 Dec;2(12):e214104. doi: 10.1001/jamahealthforum.2021.4104. eCollection 2021 Dec. PubMed PMID: 35977305; PubMed Central PMCID: PMC8796945.
Lu CY, Busch AB, Zhang F, Madden JM, Callahan MX, LeCates RF, Wallace J, Foxworth P, Soumerai SB, Ross-Degnan D, Wharam JF. Impact of High-Deductible Health Plans on Medication Use Among Individuals With Bipolar Disorder. Psychiatr Serv. 2021 Aug 1;72(8):926-934. doi: 10.1176/appi.ps.202000362. Epub 2021 May 11. PubMed PMID: 33971720.
Madden JM. Three Decades of Drug Cap Studies Are Enough. JAMA Health Forum. 2021 Jun 4;2(6):e211249. doi: 10.1001/jamahealthforum.2021.1249. PubMed PMID: 36218757.